Introduction {#s1}
============

Reduced endothelium dependent flow mediated dilation (FMD) precedes the development of atherosclerosis (Bonetti et al., [@B6]) and cardiovascular disease (CVD) (Higashi et al., [@B23]), and is a strong prognostic marker of long-term cardiovascular morbidity and mortality (Fichtlscherer et al., [@B14]). FMD is predominately mediated by the release of nitric oxide (NO), a gaseous compound with antiadhesive, antithrombotic, and vasodilatory properties (Joyner and Green, [@B25]). The effect of acute feeding has been well summarized (Thom et al., [@B46]). Both fat- and carbohydrate-rich foods generally regarded as healthful have not been shown to reduce FMD (e.g., walnuts or oatmeal) (Brock et al., [@B9]; Cortes et al., [@B12]; Karatzi et al., [@B26]). However, ingestion of meals high in refined sugars (Kawano et al., [@B27]; Title et al., [@B48]; Beckman et al., [@B5]; Ceriello et al., [@B11], [@B10]; Weiss et al., [@B52]; Xiang et al., [@B53]; Mah et al., [@B32]) and added dietary fat (Plotnick et al., [@B39]; Vogel et al., [@B51]; Bae et al., [@B4]; Gaenzer et al., [@B15]; Ceriello et al., [@B11], [@B10]; Padilla et al., [@B36]; Tushuizen et al., [@B49]; Tyldum et al., [@B50]; Credeur et al., [@B13]) have been shown to reduce FMD potentially through the induction of oxidative stress (Plotnick et al., [@B39]; Title et al., [@B48]; Bae et al., [@B4]; Tushuizen et al., [@B49]; Xiang et al., [@B53]). Thus, the postprandial state is thought to potentially facilitate atherogenesis (Zilversmit, [@B54]; Ceriello et al., [@B11]) through increased oxidative stress and reduction in NO bioavailability.

Regular exercise is associated with reductions in CVD morbidity and mortality (Arena et al., [@B1]) and improvements in endothelial function (Green et al., [@B18]). These findings are partially attributed to bolstered anti-oxidant defense systems (Ashor et al., [@B2]) which may improve NO bioavailability. In addition, acute exercise appears to be protective against postprandial reductions in vascular function. Performing acute endurance exercise several hours prior to consuming a high sugar meal prevents reduced endothelial function (Weiss et al., [@B52]). Postprandial FMD impairment following a high fat mixed meal is prevented by acute moderate intensity (Padilla et al., [@B36]) and high-intensity aerobic interval exercise (Tyldum et al., [@B50]). Acute resistance exercise prevents increased arterial stiffness following a high fat mixed meal (Augustine et al., [@B3]). Collectively, these findings indicate that regular exercise is beneficial for long-term cardiovascular health and that decrements in vascular function following a meal can be attenuated by acute exercise. However, the effects of regular exercise on postprandial endothelial function remain unexplored.

Therefore, the purpose of this study was to test the hypothesis that postprandial FMD is reduced following a high sugar or high fat mixed meal in sedentary adults, but maintained in individuals engaging in regular exercise. We also sought to determine if the type of exercise (resistance, aerobic, or cross-training) influenced postprandial FMD responses. We hypothesized that all exercisers would present favorable postprandial metabolic responses (e.g., glucose tolerance and insulin sensitivity), which may play a role in vascular responses (Augustine et al., [@B3]). Chronic exercise-induced prevention of diet-induced endothelial dysfunction might extend to protection against other lifestyle related activities shown to evoke endothelial dysfunction (Ghiadoni et al., [@B16]; Heiss et al., [@B22]; Phillips et al., [@B38]; Goslawski et al., [@B17]; Robinson et al., [@B43]), and explain some of the unaccounted for cardioprotective effects of exercise (Joyner and Green, [@B25]).

Methods {#s2}
=======

Study design and participants
-----------------------------

All protocols were approved by the Institutional Review Boards at the Medical College of Wisconsin and the University of Illinois at Chicago. Fifty-two participants were enrolled and 45 completed the study. All subjects gave verbal and written informed consent in accordance with the Declaration of Helsinki. Participants underwent an initial screen for inclusion and exclusion criteria. Adults between the ages of 18 and 40 were recruited from one of four groups: (1) sedentary adults who had not regularly engaged in any exercise training programs for the previous 6 months; (2) runners who ran an average of 15--20 miles per week over the previous 6 months; (3) weight lifters who resistance trained with free weights or machines ≥3 times per week over the previous 6 months; and 4) cross-trainers who performed both resistance exercise ≥3 times per week and ran 15--20 miles per week for the previous 6 months. Participants were excluded if they had a history of CVD, hypertension \[≥140/90 mmHg\], hypercholesterolemia, eating disorders, diagnoses with diabetes or other endocrine disorders, pregnancy, tobacco or excessive alcohol use, or use of illicit drugs.

The study was a randomized, cross over design (Figure [1](#F1){ref-type="fig"}). Participants received the high sugar meal (HSM) and the high fat mixed meal (HFMM) in randomized order to prevent an order effect. There was a 7- to 30-day washout period between visits and a subset of participants (eight sedentary group, two runners, two weight lifters and one cross-trainer) returned for a third-time control visit where no meal was consumed. Women were tested in the early follicular phase of their menstrual cycle (i.e., days 1 through six via self-report).

![Study design: Sedentary participants (*n* = 11), runners (*n* = 12), weight lifters (*n* = 13), and cross-trainers (*n* = 9) were screened, consented, and enrolled in the study. Subjects underwent a resting FMD and blood draw followed by a 75 g glucose drink (high sugar meal; HSM) or a high fat mixed meal (HFMM) followed by repeated measures FMD and blood draws at 30, 60, 120, and 180 min post-meal. Participants were instructed to drink the meals within 10 min. Blood draws were taken for determination blood glucose, insulin, and triglycerides. Following ≥ 1-week washout for males and 1-month for females, the visit was repeated for the remaining meal. Meal order was randomized.](fphys-09-00183-g0001){#F1}

Meal composition
----------------

The HSM consisted of a solely carbohydrate 75 g glucose tolerance drink (orange flavored; NERL, Trutol, Fisher Scientific; total 300 kcal). There is no protein or fat in this beverage. The HFMM was given in the form of a shake that consisted of 8 fl. oz. Vanilla Resource 2.0 (Novartis), 150 g of ice cream (Vanilla Häagen Dazs®), and 7 g of dried egg yolk powder. The HFMM nutrient profile was as follows: 50 g of fat, 19 g of saturated fat, 339 mg of cholesterol, and 82 g of carbohydrate, 46 g of which were simple sugars. (total 910 kcal). Participants were instructed to consume each meal within 10 min. Several studies have used oral glucose tolerance test beverages (i.e., HSM) to elicit hyperglycemia induced decrements in FMD (Title et al., [@B48]; Ceriello et al., [@B11]; Xiang et al., [@B53]) and we designed the macronutrient composition of our HFMM to be similar to previous studies employing standardized HFMMs (Plotnick et al., [@B39]; Vogel et al., [@B51]).

Measurement of flow- and nitroglycerin-mediated dilation
--------------------------------------------------------

Brachial artery ultrasound assessment of FMD was performed with the participants in the supine position, using an 11-MHz probe (GE Logiq 500 pro-series) as previously described (Phillips et al., [@B38]). After the initial baseline ultrasound evaluation, participants transitioned to the reclining position and were given HSM or HFMM to consume within 10 min. Brachial artery FMD was then re-assessed in the supine position at 30, 60, 120, and 180 min post-ingestion. Participants were permitted to use the restroom between measures, however participants were supine for ≥10 min before each FMD evaluation. Nitroglycerin (NTG; 0.4 mg) was administered sublingually 10 min after the 180-min FMD at both visits. Ultrasound measurements were performed immediately before, as well as continuously throughout the 5 min after NTG administration. Shear rate (s^−1^) was calculated as blood velocity (cm/s) divided by vessel diameter as previously described (Phillips et al., [@B38]). The mean blood velocity was measured simultaneously in duplex mode with the brachial artery diameter. A single investigator performed the scans and a separate single investigator performed analysis while blinded to participant groups and meal condition (i.e., HSM or HFMM). Blood pressures were taken at the upper arm using an automated BP monitor (GE Dinamap) in the supine position with the lower arm supported by a pillow at the same time points at which FMD was performed.

Blood profile measurements and analysis
---------------------------------------

Baseline blood samples were taken in the fasted condition (≥4 h) at baseline, and 30, 60, 120, and 180 min after the respective test meal. Plasma glucose concentration was measured using the glucose oxidase procedure (Beckman II autoanalyzer). Triglycerides (Stanbio), total cholesterol, and HDL- and direct LDL-cholesterol (Roche Diagnostics) were measured with spectrophotometric assays. The homeostasis model assessment for insulin resistance (HOMA-IR) was calculated as previously described (Matthews et al., [@B35]). The Matsuda insulin sensitivity index (ISI) was calculated as previously described to provide an estimate of whole body insulin sensitivity that also correlates with indices obtained from the hyperinsulinemic-euglycemic clamp (Matsuda and DeFronzo, [@B34]). Glucose and triglyceride area under the curve (AUC) for the 180 min following HSM and HFMM was calculated using the trapezoidal method to determine AUC (Le Floch et al., [@B30]) (GraphPad Prism Version 7.0; La Jolla, CA). Briefly, each time point measured is treated as a fraction of the total area. All time points are considered and combined for the total area which is computed using the trapezoid rule. We set our parameters such that baseline values were considered our theoretical "zero" and postprandial values lower than the physiological baseline are included in the model (i.e. they have a net "negative" effect on total area). High sensitivity C-reactive protein was measured with an enzyme immunoassay kit (MP Biomedicals). Superoxide dismutase (SOD) activity was assessed by measuring the dismutation of superoxide radicals generated by xanthine oxidase and hypoxanthine using a commercially available kit (Cayman Chemical).

Statistics
----------

Brachial artery diameter, percent brachial artery FMD, shear rate-normalized FMD, blood glucose, insulin, and triglycerides were assessed using two-way repeated-measures ANOVA (group × time). Clinical characteristics, CRP, and SOD, were assessed using one-way ANOVA. Where ANOVA showed a statistically significant difference (main effect or interaction), the Bonferroni-Sidak test for multiple comparisons was performed. For covariate testing, a generalized estimating equation (GEE) model was used to compare FMD change over time between groups. The same model with additional covariates (CRP, lipids, baseline BP, insulin, glucose, cholesterol, LDL, triglycerides, brachial artery diameter, shear rate, % body fat, BMI) in the model was used for testing if the covariates independently impacted the group effects on the FMD change over time. Mean ± SEM were reported and *P* \< 0.05 was considered significant.

Results {#s3}
=======

Participant characteristics
---------------------------

Table [1](#T1){ref-type="table"} documents the characteristics of each of the groups. A total of 52 participants were screened and enrolled into the study. 45 participants completed all study requirements and were included in the final analysis. The mean age was 27 ± 1 years (Table [1](#T1){ref-type="table"}). Participants in each group demonstrated normal profiles for blood pressure and blood lipids. While there was no difference in BMI or waist circumference among the groups, the sedentary participants had a significantly higher body fat percentage compared to the regular exercise groups (Table [1](#T1){ref-type="table"}; *P* \< 0.01). Plasma CRP was higher and SOD activity was lower in the SED adults compared to regular exercisers (Table [1](#T1){ref-type="table"}). While CRP levels in the sedentary group appear to be relatively high, the reported values are well within the range of detection for the particular assay used. All the other parameters were not statistically different between groups.

###### 

Data are presented as mean ± SEM.

  **Group**                   **Sedentary**   **Runners**                                  **Weight lifter**                             **Cross-trainer**                            ***P*-Value**
  --------------------------- --------------- -------------------------------------------- --------------------------------------------- -------------------------------------------- ---------------------------------------------
  Number, n (F/M)             11 (7/4)        12 (7/5)                                     13 (4/9)                                      9 (5/4)                                      --
  Age (years)                 27 ± 2          27 ± **1**                                   26 ± 1                                        26 ± 1                                       0.633
  BMI (kg/m2)                 27 ± 1          22 ± 0.4                                     24 ± 1                                        24 ± 1                                       0.076
  \% Body Fat                 31 ± 2          21 ± 2[^\*^](#TN1){ref-type="table-fn"}      23 ± 2[^\*^](#TN1){ref-type="table-fn"}       22 ± 2[^\*^](#TN1){ref-type="table-fn"}      **0.005**[^†^](#TN2){ref-type="table-fn"}
  Waist circumference (cm)    81 ± 2          73 ± 1                                       81 ± 3                                        77 ± 3                                       0.061
  Total cholesterol (mg/dl)   156 ± 4         147 ± 7                                      159 ± 15                                      161 ± 11                                     0.795
  LDL (mg/dl)                 103 ± 9         102 ± 7                                      86 ± 10                                       96 ± 6                                       0.410
  HDL (mg/dl)                 51 ± 4          46 ± 3                                       48 ± 5                                        54 ± 3                                       0.559
  Glucose (mg/dL)             94 ± 2          93 ± 3                                       90 ± 2                                        93 ± 2                                       0.622
  Insulin (μU/mL)             8.7 ± 2         8.0 ± 0.3                                    7.1 ± 1                                       6.4 ± 1                                      0.650
  HOMA-IR                     3.1 ± 0.1       2.7 ± 0.3                                    2.7 ± 0.1                                     2.7 ± 0.1                                    0.325
  C-reactive protein (mg/L)   5.2 ± 1         1.8 ± 1[^\*^](#TN1){ref-type="table-fn"}     0.9 ± 2[^\*^](#TN1){ref-type="table-fn"}      1.2 ± 0.5[^\*^](#TN1){ref-type="table-fn"}   \<**0.001**[^†^](#TN2){ref-type="table-fn"}
  SOD Activity (U/ml)         0.84 ± 0.1      1.2 ± 0.2[^\*^](#TN1){ref-type="table-fn"}   1.2 ± 0.09[^\*^](#TN1){ref-type="table-fn"}   1.4 ± 0.2[^\*^](#TN1){ref-type="table-fn"}   **0.009**[^†^](#TN2){ref-type="table-fn"}

BMI, body mass index; HDL, high density lipoprotein; LDL, low density lipoprotein; SOD, superoxide dismutase.

*Indicates significance for One-way ANOVA (P \< 0.05)*.

*Indicates significant difference observed vs. sedentary participants (P \< 0.05)*.

Vasodilator function
--------------------

Within each group, the arterial diameter was similar across baseline and at each of the postprandial time points for both HSM and HFMM consumption (see Tables [2](#T2){ref-type="table"}, [3](#T3){ref-type="table"}). Consistent with previous studies in physically active populations (Padilla et al., [@B36]; Phillips et al., [@B38]; Robinson et al., [@B43]), the sedentary participants presented a greater FMD% at baseline (see Figures [2](#F2){ref-type="fig"}, [3](#F3){ref-type="fig"}). There was no group effect for brachial artery diameter during the HSM visit (see Table [2](#T2){ref-type="table"}). There was a group effect for brachial artery diameter during the HFMM visit, but post hoc analysis did not reveal significant pairwise differences (Table [3](#T3){ref-type="table"}). Regarding peak shear rate during hyperemia, which is thought to be a primary vasodilator stimulus (Pyke and Tschakovsky, [@B40]), there was no effect of time during the HSM or HFMM visits (Tables [2](#T2){ref-type="table"}, [3](#T3){ref-type="table"}). There was a group effect for peak shear rate during the HSM visit, but post hoc analysis did not reveal significant pairwise differences (Table [2](#T2){ref-type="table"}). There was no group effect for peak shear rate during the HFMM visit (see Table [3](#T3){ref-type="table"}). Brachial artery FMD was reduced in sedentary participants after HSM as indicated by a significant main effect for time, and for select pairwise comparisons (9.9 ± 0.9% pre-HSM to 6.8 ± 1.1% at 30 min, 6.5 ± 1.0% at 60 min, and 7.3 ± 0.6% at 180 min post-HSM; *P* \< 0.05 compared to pre-HSM; Figure [2A](#F2){ref-type="fig"}). In contrast, there were no changes in FMD after HSM in any of the exercise trained groups (Figures [2B--D](#F2){ref-type="fig"}). Brachial artery FMD was also reduced in SED after HFMM, as indicated by a significant main effect for time, and for select pairwise comparisons (9.4 ± 0.9% pre-HFMM to 5.9 ± 1.2% at 120 min and 7.0 ± 0.8% at 180 min post-HFMM; *P* \< 0.05 for both; Figure [3A](#F3){ref-type="fig"}). In contrast, there were no changes in FMD after HFMM in any of the exercise trained groups (Figures [3B--D](#F3){ref-type="fig"}). In a separate control study on a subset of our participants with no intervention, repeated FMD measures were similar at all-time points (Figure [4](#F4){ref-type="fig"}). There was no difference in endothelium-independent dilation to NTG between the groups after HSM or HFMM.

###### 

Data presented as mean ± SEM.

                                    **Baseline**                              **30 min**                                **60 min**                                **120 min**                               **180 min**                               ***P*-value interaction time group**
  --------------------------------- ----------------------------------------- ----------------------------------------- ----------------------------------------- ----------------------------------------- ----------------------------------------- ----------------------------------------------
  **RESTING HR (bpm)**                                                                                                                                                                                                                                
  Sedentary                         67 ± 2                                    72 ± 3                                    71 ± 3                                    73 ± 3                                    74 ± 3                                    0.9990
  Runner                            57 ± 3                                    56 ± 3[^\*^](#TN4){ref-type="table-fn"}   58 ± 4[^\*^](#TN4){ref-type="table-fn"}   60 ± 3[^\*^](#TN4){ref-type="table-fn"}   57 ± 3[^\*^](#TN4){ref-type="table-fn"}   0.3257
  Weight lifter                     57 ± 4                                    58 ± 4[^\*^](#TN4){ref-type="table-fn"}   59 ± 3                                    60 ± 5[^\*^](#TN4){ref-type="table-fn"}   60 ± 4[^\*^](#TN4){ref-type="table-fn"}   \<**0.0001[^†^](#TN3){ref-type="table-fn"}**
  Cross-trainer                     53 ± 3[^\*^](#TN4){ref-type="table-fn"}   58 ± 4[^\*^](#TN4){ref-type="table-fn"}   60 ± 4                                    61 ± 3                                    59 ± 3[^\*^](#TN4){ref-type="table-fn"}   
  **SYSTOLIC BP (mmHg)**                                                                                                                                                                                                                              
  Sedentary                         124 ± 3                                   122 ± 4                                   119 ± 5                                   117 ± 5                                   121 ± 5                                   0.9991
  Runner                            120 ± 3                                   116 ± 2                                   113 ± 3                                   113 ± 3                                   110 ± 3                                   0.1837
  Weight lifter                     120 ± 3                                   116 ± 4                                   115 ± 4                                   113 ± 3                                   116 ± 4                                   **0.0003[^†^](#TN3){ref-type="table-fn"}**
  Cross-trainer                     112 ± 4                                   111 ± 5                                   108 ± 4                                   110 ± 4                                   109 ± 4                                   
  **DIASTOLIC BP (mmHg)**                                                                                                                                                                                                                             
  Sedentary                         54 ± 2                                    57 ± 2                                    57 ± 3                                    54 ± 3                                    56 ± 3                                    0.8154
  Runner                            57 ± 3                                    53 ± 2                                    54 ± 3                                    53 ± 2                                    53 ± 2                                    0.8198
  Weight lifter                     59 ± 2                                    55 ± 1                                    54 ± 1                                    56 ± 1                                    56 ± 1                                    0.4970
  Cross-trainer                     54 ± 1                                    54 ± 2                                    53 ± 2                                    56 ± 2                                    54 ± 2                                    
  **BASELINE ARTERY DIAM (mm)**                                                                                                                                                                                                                       
  Sedentary                         4.9 ± 0.3                                 4.9 ± 0.3                                 5.1 ± 0.3                                 5.1 ± 0.3                                 5.1 ± 0.3                                 0.9999
  Runner                            4.7 ± 0.3                                 4.7 ± 0.3                                 4.8 ± 0.3                                 4.9 ± 0.3                                 4.9 ± 0.3                                 0.9961
  Weight lifter                     5.3 ± 0.2                                 5.2 ± 0.2                                 5.3 ± 0.2                                 5.4 ± 0.2                                 5.4 ± 0.2                                 0.7456
  Cross-trainer                     4.9 ± 0.2                                 4.9 ± 0.2                                 4.9 ± 0.2                                 5.0 ± 0.2                                 5.0 ± 0.2                                 
  **PEAK SHEAR RATE (s**^−1^**)**                                                                                                                                                                                                                     
  Sedentary                         522 ± 50                                  575 ± 57                                  548 ± 46                                  513 ± 48                                  543 ± 63                                  0.9972
  Runner                            525 ± 63                                  524 ± 66                                  566 ± 60                                  574 ± 75                                  524 ± 49                                  0.7111
  Weight lifter                     465 ± 39                                  517 ± 36                                  543 ± 47                                  559 ± 56                                  511 ± 37                                  **0.0134[^†^](#TN3){ref-type="table-fn"}**
  Cross-trainer                     597 ± 47                                  585 ± 42                                  651 ± 36                                  633 ± 33                                  643 ± 51                                  

Indicates significant difference observed vs. before glucose intake (P \< 0.05).

*Indicates significant difference vs. sedentary participants at each time. BP, blood pressure; FMD, flow-mediated dilation*.

###### 

Data are presented as mean ± SEM.

                                    **Baseline**                              **30 min**                                **60 min**                                **120 min**                               **180 min**                               ***P*-value interaction time group**
  --------------------------------- ----------------------------------------- ----------------------------------------- ----------------------------------------- ----------------------------------------- ----------------------------------------- ----------------------------------------------
  **RESTING HR (bpm)**                                                                                                                                                                                                                                
  Sedentary                         68 ± 2                                    77 ± 3                                    75 ± 3                                    75 ± 3                                    75 ± 3                                    0.9802
  Runner                            57 ± 2[^\*^](#TN6){ref-type="table-fn"}   56 ± 2[^\*^](#TN6){ref-type="table-fn"}   59 ± 2[^\*^](#TN6){ref-type="table-fn"}   60 ± 3[^\*^](#TN6){ref-type="table-fn"}   57 ± 2[^\*^](#TN6){ref-type="table-fn"}   0.0669
  Weight lifter                     61 ± 3                                    63 ± 3[^\*^](#TN6){ref-type="table-fn"}   66 ± 3                                    65 ± 4                                    66 ± 3                                    \<**0.0001[^†^](#TN7){ref-type="table-fn"}**
  Cross-trainer                     53 ± 3[^\*^](#TN6){ref-type="table-fn"}   58 ± 3[^\*^](#TN6){ref-type="table-fn"}   60 ± 4[^\*^](#TN6){ref-type="table-fn"}   61 ± 3[^\*^](#TN6){ref-type="table-fn"}   59 ± 3[^\*^](#TN6){ref-type="table-fn"}   
  **SYSTOLIC BP (mmHg)**                                                                                                                                                                                                                              
  Sedentary                         121 ± 3                                   121 ± 2                                   116 ± 2                                   113 ± 4                                   112 ± 5                                   0.9763
  Runner                            120 ± 3                                   116 ± 2                                   113 ± 3                                   113 ± 2                                   110 ± 2                                   **0.0034[^†^](#TN7){ref-type="table-fn"}**
  Weight lifter                     122 ± 6                                   120 ± 4                                   122 ± 4                                   108 ± 9                                   113 ± 3                                   0.7407
  Cross-trainer                     119 ± 3                                   116 ± 3                                   119 ± 3                                   112 ± 3                                   111 ± 2                                   
  **DIASTOLIC BP (mmHg)**                                                                                                                                                                                                                             
  Sedentary                         56 ± 1                                    56 ± 2                                    53 ± 2                                    53 ± 2                                    54 ± 2                                    0.9983
  Runner                            56 ± 3                                    54 ± 3                                    52 ± 3                                    51 ± 3                                    51 ± 3                                    0.1388
  Weight lifter                     60 ± 2                                    58 ± 1                                    58 ± 1                                    56 ± 1                                    56 ± 2                                    **0.0041[^†^](#TN7){ref-type="table-fn"}**
  Cross-trainer                     56 ± 1                                    55 ± 1                                    54 ± 1                                    55 ± 1                                    55 ± 1                                    
  **BASELINE ARTERY DIAM (mm)**                                                                                                                                                                                                                       
  Sedentary                         4.8 ± 0.2                                 4.8 ± 0.2                                 4.9 ± 0.2                                 5.1 ± 0.2                                 5.1 ± 0.2                                 0.9999
  Runner                            4.8 ± 0.4                                 4.8 ± 0.3                                 4.8 ± 0.3                                 5.0 ± 0.3                                 5.0 ± 0.3                                 0.4171
  Weight lifter                     5.3 ± 0.2                                 5.2 ± 0.2                                 5.3 ± 0.2                                 5.4 ± 0.2                                 5.5 ± 0.2                                 **0.0106[^†^](#TN7){ref-type="table-fn"}**
  Cross-trainer                     4.9 ± 0.2                                 4.8 ± 0.2                                 4.8 ± 0.2                                 5.0 ± 0.2                                 5.1 ± 0.2                                 
  **PEAK SHEAR RATE (s**^−1^**)**                                                                                                                                                                                                                     
  Sedentary                         522 ± 50                                  595 ± 82                                  548 ± 51                                  544 ± 51                                  545 ± 60                                  0.9784
  Runner                            548 ± 47                                  512 ± 53                                  580 ± 50                                  560 ± 50                                  585 ± 44                                  0.4542
  Weight lifter                     485 ± 37                                  519 ± 36                                  578 ± 44                                  555 ± 46                                  504 ± 39                                  0.1927
  Cross-trainer                     532 ± 42                                  575 ± 40                                  624 ± 39                                  635 ± 45                                  609 ± 43                                  

Indicates significant difference observed vs. before high fat mixed meal (P \< 0.05).

*significant difference vs. sedentary participants at each time*.

![Brachial artery FMD responses to a 75 g glucose high sugar meal (HSM) at baseline, and 30, 60, 120, and 180 min post-ingestion in **(A)** sedentary participants (*n* = 11), **(B)** runners (*n* = 12), **(C)** weight lifters (*n* = 13), and **(D)** cross-trainers (*n* = 9). Brachial artery FMD scale is on the left Y-axis. Nitroglycerin (NTG) mediated dilation is depicted on the right Y-axis. All data presented as mean ± SEM. ^\*^Indicates significant difference compared to baseline FMD measure (adjusted *P* \< 0.05; Sidak-Bonferroni adjustment for ANOVA multiple comparisons).](fphys-09-00183-g0002){#F2}

![Brachial artery FMD responses to a high fat mixed meal (HFMM) at baseline, and 30, 60, 120, and 180 min post-ingestion in **(A)** sedentary participants (*n* = 11), **(B)** runners (*n* = 12), **(C)** weight lifters (*n* = 13), and **(D)** cross-trainers (*n* = 9). Brachial artery FMD scale is on the left Y-axis. Nitroglycerin (NTG) mediated dilation depicted on the right Y-axis. All data presented as mean ± SEM. ^\*^Indicates significant difference compared to baseline FMD measure (adjusted *P* \< 0.05; Sidak-Bonferroni adjustment for ANOVA multiple comparisons).](fphys-09-00183-g0003){#F3}

![Repeated measures of Brachial Artery FMD. As time control, a subset of participants (*n* = 13) underwent the same protocol as the HSM and HFMM trials except they were given 12 oz. water. Brachial artery FMD responses at baseline, and 30, 60, 120, and 180 min post-ingestion are shown here. All data presented as mean ± SEM.](fphys-09-00183-g0004){#F4}

Hemodynamics and biochemical analyses
-------------------------------------

There was no effect of HSM on SBP, but there was a significant group effect (Table [2](#T2){ref-type="table"}). Post hoc analysis revealed no pairwise differences. There was a time effect of HFMM on SBP, but again no pairwise differences (Table [3](#T3){ref-type="table"}). There was no effect of HSM on DBP and there were no group differences (Table [2](#T2){ref-type="table"}). There was a significant group difference during the HFMM visit but no pairwise differences (Table [3](#T3){ref-type="table"}). Fasting insulin and blood glucose levels were similar among all groups (Table [1](#T1){ref-type="table"}). In a pooled analysis, glucose and insulin responses to HSM were increased in sedentary participants compared to exercisers (significant group and interaction effect; see Figures [5A,B](#F5){ref-type="fig"}). The Matsuda ISI was higher in exercisers, indicating greater insulin sensitivity (Figure [5C](#F5){ref-type="fig"}). Glucose AUC~0−180min~ was higher in SED participants compared to exercisers (Figure [5D](#F5){ref-type="fig"}). There was a significant group effect for postprandial triglycerides and triglyceride AUC~0−180min~ was higher in SED participants compared to exercisers following HSM (Figures [6A,B](#F6){ref-type="fig"}).

![Glucose homeostatic responses to a 75 g glucose high sugar meal (HSM) at baseline, and 30, 60, 120, and 180 min post-ingestion in sedentary participants (*n* = 11) and exercisers (*n* = 33). **(A)** Blood glucose response over 180 min. **(B)** Serum insulin levels over 180 min. **(C)** Matsuda insulin sensitivity index (ISI) and **(D)** Glucose are under the curve (AUC) over the 180 min postprandial period. All data presented as mean ± SEM. ^†^Indicates significant main or interaction effect (*P* \< 0.05). ^\*^Indicates significant difference between sedentary participants and exercisers (adjusted *P* \< 0.05; Sidak-Bonferroni adjustment for ANOVA multiple comparisons).](fphys-09-00183-g0005){#F5}

![Serum triglycerides responses to a 75 g glucose high sugar meal (HSM) at baseline, and 30, 60, 120, and 180 min post-ingestion in sedentary participants (*n* = 11) and exercisers (*n* = 33). **(A)** Serum triglyceride levels over 180 min. and **(B)** Serum triglyceride area under the curve (AUC) over the 180 min postprandial period. All data presented as mean ± SEM. ^†^Indicates significant main or interaction effect (*P* \< 0.05). ^\*^Indicates significant difference between sedentary participants and exercisers (adjusted *P* \< 0.05; Sidak-Bonferroni adjustment for ANOVA multiple comparisons).](fphys-09-00183-g0006){#F6}

Glucose and insulin concentrations were significantly greater in response to HFMM in SED participants compared to exercisers (significant group effect; see Figures [7A,B](#F7){ref-type="fig"}). In contrast to HSM, the Matsuda index was not different between sedentary participants compared to exercisers after HFMM, although there was a trend for elevated Matsuda index in the exercisers compared to SED participants (*P* = 0.078; Figure [7C](#F7){ref-type="fig"}). Glucose AUC~0−180min~ was higher in SED participants compared to exercisers following HFMM (*P* = 0.049; Figure [7D](#F7){ref-type="fig"}). There was a significant group effect for postprandial triglycerides (Figure [8A](#F8){ref-type="fig"}) but no difference between SED participants and exercisers triglyceride AUC~0−180min~ following HFMM (Figure [8B](#F8){ref-type="fig"}). The postprandial glycemia after HSM was greater than HFMM and postprandial lipemia after HFMM was greater than HSM.

![Glucose homeostatic responses to a high fat mixed meal (HFMM) at baseline, and 30, 60, 120, and 180 min post-ingestion in sedentary participants (*n* = 11) and exercisers (*n* = 33). **(A)** Blood glucose response over 180 min. **(B)** Serum insulin levels over 180 min. **(C)** Matsuda insulin sensitivity index (ISI) and **(D)** Glucose are under the curve (AUC) over the 180 min postprandial period. All data presented as mean ± SEM. ^†^Indicates significant main or interaction effect (*P* \< 0.05). ^\*^Indicates significant difference between sedentary participants and exercisers (adjusted *P* \< 0.05 after Sidak-Bonferroni adjustment).](fphys-09-00183-g0007){#F7}

![Serum triglyceride responses to a high fat mixed meal (HFMM) at baseline, and 30, 60, 120, and 180 min post-ingestion in sedentary participants (*n* = 11) and exercisers (*n* = 33). **(A)** Serum triglyceride levels over 180 min. and **(B)** Serum triglyceride area under the curve (AUC) over the 180 min postprandial period. All data presented as mean ± SEM. ^†^Indicates significant main or interaction effect (*P* \< 0.05). ^\*^Indicates significant difference between sedentary participants and exercisers (adjusted *P* \< 0.05; Sidak-Bonferroni adjustment for ANOVA multiple comparisons).](fphys-09-00183-g0008){#F8}

In regard to pooling the exercisers\' metabolic response data, glucose and insulin responses were similar between groups following HSM (Figures [9A,B](#F9){ref-type="fig"}) and HFMM (Figures [10A,B](#F10){ref-type="fig"}). However, weight lifters did exhibit lower insulin sensitivity following HSM compared to cross-trainers (Figure [9C](#F9){ref-type="fig"}) and there was a significant group effect for triglyceride responses to HSM (Figure [9D](#F9){ref-type="fig"}). Similarly, weight lifters exhibited lower insulin sensitivity following HFMM compared to cross-trainers (Figure [10C](#F10){ref-type="fig"}) and there was a significant group effect for triglyceride responses to HFMM (Figure [10D](#F10){ref-type="fig"}).

![Metabolic responses at baseline, and 30, 60, 90, 120, and 180 min to a 75 g glucose high sugar meal (HSM) in runners (*n* = 11), weightlifters (*n* = 13), and cross-trainers (*n* = 9). **(A)** Blood glucose response over 180 min. **(B)** Serum insulin levels over 180 min **(C)** Matsuda insulin sensitivity index (ISI) and **(D)** Serum triglyceride levels over 180 min. All data presented as mean ± SEM. ^†^Indicates significant main or interaction effect (*P* \< 0.05). ^\*^Indicates significant difference between groups (adjusted *P* \< 0.05; Sidak-Bonferroni adjustment for ANOVA multiple comparisons).](fphys-09-00183-g0009){#F9}

![Metabolic responses at baseline, and 30, 60, 90, 120, and 180 min to a high fat mixed meal (HFMM) in runners (*n* = 11), weightlifters (*n* = 13), and cross-trainers (*n* = 9). **(A)** Blood glucose response over 180 min. **(B)** Serum insulin levels over 180 min. **(C)** Matsuda insulin sensitivity index (ISI) and **(D)** Serum triglyceride levels over 180 min. All data presented as mean ± SEM. ^†^Indicates significant main or interaction effect (*P* \< 0.05). ^\*^Indicates significant difference between groups (adjusted *P* \< 0.05; Sidak-Bonferroni adjustment for ANOVA multiple comparisons).](fphys-09-00183-g0010){#F10}

Discussion {#s4}
==========

The primary findings of this study are that a single high sugar meal and high fat mixed meal reduce postprandial FMD in sedentary participants, but not in participants performing regular aerobic or resistance exercise. There was not a differential or a combined effect of aerobic and resistance exercise (i.e., cross-training) on postprandial FMD. Favorable metabolic responses to the feedings appear to have influenced the favorable postprandial FMD response in exercisers compared to sedentary participants. In addition, exercisers exhibited lower baseline plasma hs-CRP, a marker of inflammation, and higher SOD activity, an endogenous anti-oxidant compared to sedentary participants. Thus, exercisers may have been protected from postprandial glycemia- and lipemia-induced inflammation and oxidative stress ultimately resulting in a reduction in post-prandial FMD in SED participants.

We have previously demonstrated that endothelial dysfunction is associated with insulin resistance, suggesting that postprandial endothelial function may represent an important link in the development of insulin resistance (Mahmoud et al., [@B33]). Furthermore, postprandial hyperglycemia is a risk factor for CVD. Borderline high (100--140 mg/dl) postprandial glycemia has been shown to be one of the earliest signs of glucose dysregulation that precedes the development of atherosclerosis (Leiter et al., [@B31]). Consistent with this, we found that the postprandial glucose response to HSM and HFMM was increased in sedentary participants compared to regular exercisers. Since the magnitude of postprandial glycemia responses to high sugar were higher in SED participants, it is possible that the lower exposure to circulating glucose may explain the differences in postprandial FMD between SED participants and regular exercisers following HSM and HFMM. Title et al. ([@B48]) demonstrated anti-oxidant treatment prevents decreased postprandial FMD without altering blood glucose following an oral 75 g glucose load in healthy participants. Collectively, these findings suggest that the greater postprandial glycemia in sedentary participants may have induced more vascular oxidative stress. Postprandial lipemia also may have been associated with excess oxidative stress.

Gaenzer et al. ([@B15]) demonstrated impaired postprandial FMD following ingestion of a standardized fatty meal, and found that FMD correlated inversely with the magnitude of postprandial lipemia. In agreement, we found that sedentary participants had impaired postprandial FMD and had a larger postprandial elevation in triglycerides compared to the exercisers following both meals, particularly HFMM. SED participants\' heightened levels of CRP and decreased SOD activity may have contributed to a potential interaction between increased postprandial lipemia, inflammation, and oxidative stress. *In vitro* studies have shown treatment of endothelial cells with free fatty acids impairs nitric oxide synthase production of NO through the inflammatory IKKβ/NFkβ pathway (Kim et al., [@B28]). Previous studies also indicate CRP plays a role in the activation of NFkβ (Jialal and Devaraj, [@B24]). High fat feedings in rodents have been shown to induce prolonged postprandial activation of inflammation and subsequent elevation in reactive oxygen species (Patel et al., [@B37]). Postprandial lipemia did not appear to impair the endothelial-independent dilations to NTG, as the reported values here are similar to our previous studies (Phillips et al., [@B38]; Robinson et al., [@B43]). This finding suggests that reduced NO bioavailability, rather than reduced NO sensitivity, contributes to the reduced FMD in the postprandial state. This finding is also in agreement with an elegant study conducted by Steinberg et al. ([@B45]) whereby both exogenous and endogenous means of elevating free fatty acids in the human circulation resulted in suppression of endothelium-dependent, but not endothelium-independent induced dilation.

In conjunction with other studies showing that impaired endothelium function after a high sugar or high fat meal can be prevented by antioxidant treatment, our current findings support the notion that postprandial glycemia and lipemia reduce NO bioavailability in sedentary adults through an increase in oxidative stress (Plotnick et al., [@B39]; Title et al., [@B48]; Beckman et al., [@B5]; Xiang et al., [@B53]). Regular exercise may serve as a potent stimulus that results in adaptations that prevent such occurrences, such as improving insulin sensitivity and up-regulating endogenous anti-oxidant expression and/or activation (Rush et al., [@B44]; Robinson et al., [@B42], [@B41]). Previous studies indicate that even short term inactivity can result in impaired FMD and insulin resistance (Hamburg et al., [@B21]; Boyle et al., [@B8]), while numerous studies indicate exercise improves insulin sensitivity (Borghouts and Keizer, [@B7]). Furthermore, exercise increases shear stress in the vasculature, which up-regulates antioxidant enzymes such as SOD and nitric oxide synthase expression (Rush et al., [@B44]; Hambrecht et al., [@B20]; Robinson et al., [@B42], [@B41]). SOD promotes NO bioavailability by preventing superoxide induced scavenging of NO. Chronic exercise training also increases circulating levels of NO metabolites (Kingwell et al., [@B29]) suggesting that preservation of NO signaling in the face of oxidative stress may have been a mechanism by which FMD was preserved in exercisers, but not in the sedentary participants. We acknowledge resting FMD was lower in the exercise groups compared to the sedentary group and this is in agreement with previous studies (Tinken et al., [@B47]). It is thought that over time in the exercised vasculature functional changes in conduit arteries occur rapidly (i.e., improved FMD) and precede longer-term (at least several weeks) arterial remodeling *in vivo* (Green et al., [@B19]).

Limitations of this study include that training differences between sedentary participants and regular exercisers were not confirmed using aerobic exercise capacity (VO~2max~). Our participants were required to refrain from exercise for at least 24 h prior to study visits. However, repeated measures would need to be conducted to determine the duration from the last bout of acute exercise that regular exercise confers postprandial vascular protection. Without performing a glycemic and lipidemic clamps we were unable to determine if postprandial differences in FMD blood were solely attributable to the differences in postprandial glucose and lipids or if exercise induced upregulation in endogenous anti-oxidants were the primary mediators of preserved postprandial FMD in exercisers (i.e., exercisers experience less oxidative stress to a given amount of glucose or TRG exposure). We did not anticipate vascular smooth muscle dysfunction in our cohort given that the participants were young and healthy. Therefore, we did not have the participants take the NTG twice (i.e. pre- and postprandial). Postprandial NTG-mediated dilation was robust suggesting vascular smooth muscle function was not affected, however it was taken 3 h postprandial and that prevents us from concluding there was not vascular smooth muscle dysfunction in the more immediate postprandial period. Our sample size was not adequately powered to investigate potential sex or racial differences given the number of groups and time points. However, several other important considerations were made during interpretation, and highlight the strength of our findings. For instance, the resting baseline arterial diameter was not different between experimental groups, apart from the resistance exercise group appearing to have a slightly larger baseline diameter. The FMD baseline diameters and shear rates at postprandial time points after HSM and HFMM were also similar within groups, suggesting that changes in diameter or the shear stimulus for FMD were not responsible for any alterations observed in the postprandial FMD results (Pyke and Tschakovsky, [@B40]). To be expected, there were differences in body fat % observed between our sedentary participants and exercisers. We hypothesized this could potentially contribute to the differences in FMD responses to HSM or HFMM as more muscle mass may have contributed to greater insulin sensitivity.

Perspectives
------------

The results of this study indicate that flow-mediated dilation is maintained after a high sugar and a high fat mixed meal in individuals performing regular exercise. This protection does not appear to be dependent on the mode of exercise training (aerobic vs. resistance exercise vs. cross-training) indicating that these modalities afford similar protection of the endothelium against exposure to hyperglycemia and hyperlipidemia. It is known that exercise protects against CVD more so than would be predicted by a reduction in traditional risk factors alone (Joyner and Green, [@B25]). This preserved peripheral vascular function in the post-prandial state may be one mean through which regular exercise protects against insulin resistance and cardiovascular risk.
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CRP

:   C-reactive protein

CVD

:   cardiovascular disease

FMD

:   flow mediated dilation

HFMM

:   high fat mixed meal
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:   high sugar meal
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